Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Ductal Adenocarcinoma Of The Prostate: Clinical Features And Implications After Local Therapy
UroToday.com - On occasion, urologists will encounter subtypes of prostate cancer (CaP) other than adenocarcinoma. One such subtype is ductal (or endometrioid) CaP. Ductal CaP is characterized by the presence of tall, pseudostratified columnar cells with abundant cytoplasm arranged in a papillary pattern. It can be diagnosed with high Gleason score and advanced stage, but its clinical course has been relatively undefined. In the online version of Cancer, Dr. Shi-Ming Tu and colleagues report a series of 108 patients with ductal CaP.
generic viagra online
UN And WHO Heads Meet Vaccine Manufacturers
World Health Organization (WHO) Director-General Dr Margaret Chan and United Nations Secretary-General Ban Ki-moon met with over 30 vaccine manufacturers from developing and developed countries at WHO headquarters today. Both the Director-General and the Secretary-General stressed the importance of assuring that any eventual vaccine for Influenza A(H1N1) was made available in a spirit of equity and fairness, and invited the manufacturers to continue to work with them to develop a strategy for this. Industry representatives affirmed their wish to cooperate in making supplies available to developing countries, and said they stood ready to produce the vaccine when requested.
News of the day
Inovio Biomedical H1N1 Influenza DNA Vaccines Demonstrate 100% Responses Against Swine Flu In Vaccinated Pigs
Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that the company"s SynCon™ H1N1 influenza DNA vaccines achieved protective antibody responses against H1N1 swine influenza virus (A/Swine/Iowa/35233/1999) in 100% of pigs immunized with a two-dose vaccine regimen.
Diagnostics

MEDEC Commends The Ontario Government's Decision To Make PET Scans More Accessible To Patients In The Province

MEDEC - Canada"s Medical Technology Companies - applauds the Ontario Government for its recent decision to add Positron Emission Tomography (PET) Technology to the services covered by the Ontario Health Insurance Plan (OHIP) thereby ensuring that Ontarians have access to PET technology. MEDEC Vice President Corporate Affairs, Lawrence Sereacki praised the actions of the Ontario government, noting that this is an opportune time for the government to modify its PET policy to help resolve the medical isotope dilemma and enhance the expeditious review and adoption of new technology for the benefit of patients. He added that MEDEC looks forward to working with the government and acting as a re to ensure smooth implementation of PET access for Ontarians. "PET scan technology is well recognized by Health Canada and others around the world" he said. "We are pleased that the government has decided to make this modern medical technology available to a wide cross section of Ontarians. Historically, Ontario had taken a decision to restrict PET scans. MEDEC had repeatedly stressed in the past that this restrictive access to PET technology has disadvantaged Ontario residents who needed access to PET scans for appropriate diagnosis and treatment and created a disparity between access to health care in Ontario versus other provinces. While applauding the province"s new step towards improving access to health technologies, MEDEC sees the need for the Ontario government to make additional changes to expeditiously assess and make modern technology more rapidly available to Ontario patients. Additionally, MEDEC recommends that the Ontario Government set up a Medical Device Technology Fund to finance technologies recommended by the Ontario Health Technology Advisory Committee (OHTAC) to improve patient access to advanced medical technologies and ensure hospitals and healthcare facilities offer advanced technologies that can save lives. MEDEC


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009